Short answer
ArriVent BioPharma, Inc. (AVBP) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected Healy, Hohneker, and Lutzker as Class II directors through the 2029 annual meeting.
ArriVent BioPharma, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected Healy, Hohneker, and Lutzker as Class II directors through the 2029 annual meeting
- Director support varied materially: Lutzker 29,495,923 votes versus Healy 18,058,285
- Meeting quorum represented 33,418,793 shares, or 72.07% of eligible shares
- Stockholders overwhelmingly ratified PwC as independent auditor for fiscal 2026, with 33,411,773 votes for and 829 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ArriVent BioPharma, Inc. 8-K filings
Get the next AVBP 8-K as it lands
Follow AVBP for push alerts, or ask the research agent what this filing means.